- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06198790
Postoperative Anemia After Bariatric Surgery
July 31, 2025 updated by: Yuntao Nie, China-Japan Friendship Hospital
To investigate the real incidence of short and long-term anemia after bariatric surgery, and explore the risk factors.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study aims to investigate the real incidence of short and long-term anemia after bariatric surgery and explore the risk factors.
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yuntao Nie, M.D.
- Phone Number: +8618611835860
- Email: nytnyt1231@163.com
Study Contact Backup
- Name: Hua Meng, M.D.
- Phone Number: +8618611457779
- Email: menghuade@hotmail.com
Study Locations
-
-
-
Beijing, China, 100029
- Recruiting
- Yuntao Nie
-
Contact:
- Yuntao Nie, M.D.
- Phone Number: +8618611835860
- Email: nytnyt1231@163.com
-
Contact:
- Hua Meng, M.D.
- Phone Number: +8618611457779
- Email: menghuade@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Patients without anemia at baseline who will undergo bariatric surgery will be included.
Description
Inclusion Criteria:
- Patients who will undergo sleeve gastrectomy or Roux-en-Y gastric bypass
- Aged between 16 and 70 years
- Patients who is not diagnosed as anemia at baseline
Exclusion Criteria:
- Patients who have anemia at baseline
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of anemia after 1, 3, 5, 10 years
Time Frame: 10 years
|
Incidence of anemia after 1, 3, 5, 10 years
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of anemia-related nutrient deficiencies
Time Frame: 10 years
|
Incidence of folate, ferritin, vitamin B12, and iron deficiencies
|
10 years
|
|
Hazard ratios for the risk factors of postoperative anemia
Time Frame: 10 years
|
Hazard ratios for the risk factors of postoperative anemia will be calculated by Cox regression model.
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yuntao Nie, M.D., China-Japan Friendship Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
December 27, 2023
First Submitted That Met QC Criteria
December 27, 2023
First Posted (Actual)
January 10, 2024
Study Record Updates
Last Update Posted (Actual)
August 3, 2025
Last Update Submitted That Met QC Criteria
July 31, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CJBariatric005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data should be accessed with the permission of the principal investigator.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
ESI-PGIMSR, BasaidarapurCompletedAnemia | Iron Deficiency Anemia of Pregnancy | Iron Deficiency Anemia Treatment | Anemia, Postpartum | FCMIndia
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Italy, Spain, United Kingdom, Hungary
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
China Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingAutoimmune Hemolytic AnemiaChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingSevere Aplastic Anemia | Refractory Aplastic Anemia | Newly Diagnosed Aplastic Anemia
-
Chinese PLA General HospitalBeijing Friendship Hospital; Beijing 302 Hospital; The University of Hong Kong-Shenzhen... and other collaboratorsEnrolling by invitationSevere Aplastic Anemia | Severe Aplastic Anemia (SAA) | Severe Aplastic Anemia, RefractoryChina
-
Incyte CorporationTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom, Belgium